14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $21.75 $29.07 Wednesday, 24th Apr 2024 ARWR stock ended at $23.29. This is 2.06% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 3.71% from a day low at $22.89 to a day high of $23.74.
90 days $21.75 $36.72
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
Aug 11, 2023 $28.79 $29.19 $28.56 $28.85 596 508
Aug 10, 2023 $29.01 $29.37 $28.65 $28.97 666 722
Aug 09, 2023 $27.50 $29.37 $27.28 $29.01 1 480 482
Aug 08, 2023 $29.63 $29.65 $26.93 $27.49 2 663 838
Aug 07, 2023 $31.65 $31.79 $30.72 $30.81 764 024
Aug 04, 2023 $32.31 $32.74 $31.57 $31.65 636 112
Aug 03, 2023 $32.85 $32.89 $32.10 $32.32 673 388
Aug 02, 2023 $33.26 $33.59 $32.63 $32.97 876 899
Aug 01, 2023 $34.37 $34.46 $33.52 $33.68 1 015 339
Jul 31, 2023 $35.13 $35.69 $34.35 $34.52 593 873
Jul 28, 2023 $36.07 $36.20 $35.02 $35.13 577 047
Jul 27, 2023 $35.34 $36.27 $35.21 $35.83 1 316 670
Jul 26, 2023 $35.69 $35.99 $35.05 $35.10 792 458
Jul 25, 2023 $34.87 $35.70 $34.87 $35.62 663 354
Jul 24, 2023 $35.99 $36.43 $34.85 $35.06 761 867
Jul 21, 2023 $35.31 $36.12 $34.84 $36.08 872 100
Jul 20, 2023 $34.75 $35.40 $34.51 $34.82 664 101
Jul 19, 2023 $35.25 $35.42 $34.28 $34.57 514 561
Jul 18, 2023 $34.70 $35.17 $34.58 $34.99 643 773
Jul 17, 2023 $34.40 $35.70 $34.40 $34.70 1 140 892
Jul 14, 2023 $34.60 $34.67 $34.14 $34.60 838 868
Jul 13, 2023 $34.09 $34.77 $33.90 $34.49 617 080
Jul 12, 2023 $34.87 $34.87 $33.82 $33.92 703 771
Jul 11, 2023 $33.92 $34.42 $33.34 $34.29 682 442
Jul 10, 2023 $33.10 $34.12 $32.73 $33.98 1 147 617
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT